Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT01880658
Brief Title: Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer (CAMCO)

First Submitted : June 5, 2013
First Submitted that Met QC Criteria : June 15, 2013
First Posted : June 19, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : February 8, 2014
Last Update Posted : February 11, 2014 (Estimate)